OvaScience Announces Ravi Mehrotra, Ph.D., Joins As Chief Corporate Development Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that Ravi Mehrotra, Ph.D., has joined the Company as Chief Corporate Development Officer. Dr. Mehrotra joins OvaScience from Credit Suisse LLC, where he served as Global Head of Biotechnology Equity Research.

Help employers find you! Check out all the jobs and post your resume.